Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inflammation × dapagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Polycystic Ovary Syndrome 4 Prostatic Neoplasms 2 Solid Tumors 1 Pediatric Brain Tumor 1 Pancreatic Neoplasms 1 Obesity 1 Lung Neoplasms 1 Inflammation 1 Hyperinsulinism 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Heart Failure 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Cardiotoxicity 1 Adenocarcinoma of Lung 1

Interventions

Exercise 5 Omeprazole 3 Etanercept 3 salicylsalicylic acid 2 palbociclib 2 XENP 1595 2 Vitamin D 2 Tea 2 Tablets 2 Sufentanil 2 Resistance Training 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Dexmedetomidine 2 Colchicine 2 Aspirin 2 Ascorbic Acid 2 soybean oil, phospholipid emulsion 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dolutegravir 1 dapagliflozin 1 cytisine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07245069 2025-11-24

Alpaca

University Medical Centre Ljubljana

Phase 2 Recruiting

Breast Neoplasms, Heart Failure, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡